Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1148020190440020087
Á¶¼±´ëÇб³ÀÇ´ë³í¹®Áý
2019 Volume.44 No. 2 p.87 ~ p.93
Effect of gonadotropin-releasing hormone agonist treatment in boys
Cho Ah-Young

Lee Jae-Hee
Kim Eun-Young
Abstract
Central precocious puberty (CPP) is less common in boys than girls; very little data is reported on effect of gonadotropin-releasing hormone analog (GnRHa) treatment in boys with CPP. The aim of the study was to evaluate growth changes in boys with CPP and early puberty (EP) treated with GnRHa therapy for 1 year. In 60 (39 CPP and 21 EP) boys with confirmed diagnosis of CPP and EP, auxological [height, height standard deviation score (Ht SDS), bone age (BA), Predicted adult height (PAH)] and endocrinological parameters were obtained at baseline, at 6 months, and at 1 year after GnRHa treatment in boys with CPP and EP. During the treatment a decline in Ht SDS and growth velocity, luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone levels were observed (p£¼0.01); and a deceleration in the maturation of bones after 1 year GnRHa treatment was observed (p£¼0.01). PAH SDS was increased during treatment with GnRHa (p£¼0.01). There was significant difference in PAH SDS between organic CPP and non-organic CPP (p£¼0.05). The present data indicate that GnRHa therapy significantly improves growth prognosis in boys with CPP and EP.
KEYWORD
Central precocious puberty, Gonadotropin releasing hormone, Height
FullTexts / Linksout information
Listed journal information